Strong Full-Year Financial Performance
Adjusted EBITDA of approximately $2.9 billion for FY2025 (vs. a referenced mid-cycle ~$2.5B, ~+16%). Net earnings attributable to common stockholders ~ $1.5 billion, or $8.97 per diluted share.
Robust Quarterly Results
Q4 2025 net earnings of $404 million, or $2.59 per diluted share; Q4 EBITDA $731 million and adjusted EBITDA $821 million.
High Operational Output and Utilization
Produced 10.1 million tons of gross ammonia in 2025 at a 97% utilization rate.
Strong Cash Generation and Capital Returns
Net cash from operations of $2.75 billion and free cash flow of ~ $1.8 billion in 2025 (up from $1.5B the year prior, ~+20%). Returned $1.7 billion to shareholders, including $1.3B used to repurchase 16.6 million shares (~10% of outstanding shares at the beginning of the year).
Balance Sheet / Financing Actions
Completed $1 billion senior notes offering to refinance $750 million maturing in Dec 2026 and strengthen financial flexibility.
Progress on Blue Point JV and Growth Platform
Blue Point (JV with JERA and Mitsui) achieved positive FID and all planned milestones through year-end, partners secured offtake and received Japanese contract-for-difference awards; civil work expected to begin Q2 2026. Project capex forecast $3.7B (CF 40%); $500M contingency remains.
Decarbonization & Low‑Carbon Product Traction
Donaldsonville CCS in operation; expected sequestration of just under 1.5 million tons of CO2 in 2026 (vs ~700k in prior year). Management reported first low‑carbon ammonia sales and growing customer willingness to pay premiums for low‑carbon product (Europe, Asia, Africa, and domestic pilots such as with POET).
Share Repurchase Program Continuation
Completed $3.0B repurchase program; commenced new $2.0B program authorized in 2025 with approximately $1.7B remaining (program expires Dec 2029).